Cemex Analysts Slash Their Forecasts After Q3 Results

Benzinga

29 Oct 2024

CEMEX, S.A.B. de C.V. (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.

Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.

Cemex shares fell 8.7% to close at $5.46 on Monday.

These analysts made changes to their price targets on Cemex following earnings announcement.

JP Morgan analyst Adrian Huerta downgraded Cemex from Overweight to Neutral and lowered the price target from $7 to $6.
Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.

Considering buying CX stock? Here’s what analysts think:

Read More:

Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2479540201"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2479540201\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2479540201?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-29 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479540201","market":"us","top_or_hot":-1,"title":"Cemex Analysts Slash Their Forecasts After Q3 Results","media":"Benzinga","content":"<html><body><p><strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.</p>\n<p>Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.</p>\n<p>Cemex shares fell 8.7% to close at $5.46 on Monday.</p>\n<p>These analysts made changes to their price targets on Cemex following earnings announcement.</p>\n<ul>\n<li>JP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.</li>\n<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>\n</ul>\n<p><strong>Considering buying CX stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"512\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w\" width=\"1024\"/></figure>\n<p><strong>Read More: </strong></p>\n<ul>\n<li><strong>Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone</strong></li>\n</ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cemex Analysts Slash Their Forecasts After Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCemex Analysts Slash Their Forecasts After Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2024-10-29 21:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.</p>\n<p>Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.</p>\n<p>Cemex shares fell 8.7% to close at $5.46 on Monday.</p>\n<p>These analysts made changes to their price targets on Cemex following earnings announcement.</p>\n<ul>\n<li>JP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.</li>\n<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>\n</ul>\n<p><strong>Considering buying CX stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"512\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w\" width=\"1024\"/></figure>\n<p><strong>Read More: </strong></p>\n<ul>\n<li><strong>Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone</strong></li>\n</ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0079474960.USD","symbol_name":"联博美国增长基金A","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/24/10/41598978/cemex-analysts-slash-their-forecasts-after-q3-results","article_id":"2479540201","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479540201","pubTimestamp":1730207199,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0079474960.USD":"联博美国增长基金A","BK4548":"巴美列捷福持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0080751232.USD":"富达环球多元动力基金A","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0061474960.USD":"天利环球焦点基金AU Acc","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","LU0109392836.USD":"富兰克林科技股A","LU0058720904.USD":"联博国际健康护理基金A","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","BK4507":"流媒体概念","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","CX":"西麦斯","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","BK4503":"景林资产持仓","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4561":"索罗斯持仓","LU0234570918.USD":"高盛全球核心股票组合Acc Close","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC"},"translate_title":"Cemex分析师在第三季度业绩公布后大幅下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CX":0.9},"content_text":"CEMEX, S.A.B. de C.V. (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.\nCemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.\nCemex shares fell 8.7% to close at $5.46 on Monday.\nThese analysts made changes to their price targets on Cemex following earnings announcement.\n\nJP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.\nBarclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.\n\nConsidering buying CX stock? Here’s what analysts think: \n\nRead More: \n\nDow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}